Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Baird raised the price target for Ryder System Inc (NYSE:R) from $253 to $290. Baird analyst Dan Moore maintained an Outperform rating. Ryder shares closed at $274.66 on Tuesday. See how other analysts view this stock.
- BTIG cut Velocity Financial Inc (NYSE:VEL) price target from $23 to $22. BTIG analyst Douglas Harter maintained a Buy rating. Velocity Financial shares closed at $17.74 on Tuesday. See how other analysts view this stock.
- Baird raised price target for J B Hunt Transport Services Inc (NASDAQ:JBHT) from $275 to $290. Baird analyst Daniel Moore maintained an Outperform rating. J B Hunt shares closed at $279.82 on Tuesday. See how other analysts view this stock.
- Needham increased the price target for Glaukos Corp (NYSE:GKOS) from $136 to $150. Needham analyst David Saxon maintained a Buy rating. Glaukos shares closed at $127.53 on Tuesday. See how other analysts view this stock.
- B of A Securities raised CSX Corp (NASDAQ:CSX) price target from $51 to $53. B of A Securities analyst Ken Hoexter maintained a Buy rating. CSX shares closed at $46.90 on Tuesday. See how other analysts view this stock.
- Morgan Stanley raised Charles River Lbrtrs ntrntl Inc (NYSE:CRL) price target from $185 to $220. Morgan Stanley analyst Ricky Goldwasser upgraded the stock from Equal-Weight to Overweight. Charles River shares closed at $184.79 on Tuesday. See how other analysts view this stock.
- Bernstein raised Delta Air Lines Inc (NYSE:DAL) price target from $88 to $93. Bernstein analyst David Vernon maintained an Outperform rating. Delta Air shares closed at $83.14 on Tuesday. See how other analysts view this stock.
- Morgan Stanley cut the price target for Resmed Inc (NYSE:RMD) from $286 to $230. Morgan Stanley analyst David Bailey downgraded the stock from Overweight to Equal-Weight. Resmed shares closed at $193.94 on Tuesday. See how other analysts view this stock.
- Goldman Sachs increased Edgewise Therapeutics Inc (NASDAQ:EWTX) price target from $20 to $32. Goldman Sachs analyst Paul Choi maintained a Neutral rating. Edgewise Therapeutics shares closed at $33.95 on Tuesday. See how other analysts view this stock.
- Morgan Stanley slashed Iqvia Holdings Inc (NYSE:IQV) price target from $225 to $200. Morgan Stanley analyst Kallum Titchmarsh downgraded the stock from Overweight to Equal-Weight. Iqvia shares closed at $179.17 on Tuesday. See how other analysts view this stock.
Considering buying DAL stock? Here’s what analysts think:
Photo via Shutterstock